You are here: >  Home Page > Shop >


The abstract of this article is free to access. Subscribers to this volume should login to gain access to the article; non-subscribers can either purchase the article or a subscription.

View basket / Proceed to Checkout

Original article

Viral suppression is comparable with 0.5 mg and 1.0 mg daily doses of entecavir in treatment-naive HBV-related decompensated cirrhosis

Amit Goel, Sumit Rungta, Prashant Verma, Abhai Verma, Ajay Narayan Verma, Praveer Rai, Rakesh Aggarwal

Antiviral Therapy 2020; 25:267-273
Cost: £20.00 excl. VAT

< Back to Previous page
Copyright © 2021 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.